7 results
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
for the treatment ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation ... Management #Hematology #Oncology
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
Treatment algorithm ... thrombosis in cancer ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm ... #Anticoagulation
Clotmaster Consensus 2019: Duration of Therapy for Venous Thromboembolic Disease
 • Superficial Venous Thrombosis
 • Upper
/Muscular Vein Thrombosis ... Thrombophilia • Cancer ... DeLoughery @Bloodman #VTE ... #anticoagulation ... hematology #length #treatment
Causes of Breakthrough/Extension of Thrombosis and Management Algorithm

#Anticoagulation #Breakthrough #Thrombosis #Algorithm #Extension #VTE #DVT #Hematology #Management
and Management Algorithm ... #Anticoagulation ... #Algorithm #Extension ... #VTE #DVT #Hematology ... #Management #Diagnosis
Algorithm for the diagnosis and management of iliofemoral deep vein thrombosis (DVT). In the absence of
Algorithm for the ... diagnosis and management ... iliofemoral deep vein thrombosis ... CAT = cancer-associated ... #dvt #vte #thromboembolism
Longterm Venous Thromboembolism Treatment Algorithm
Treat for 3 months and reassess
 • Isolated distal DVT (without cancer)
Thromboembolism Treatment ... Algorithm Treat ... therapy - Second VTE ... #Algorithm #management ... #hematology #anticoagulation
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
MI, stroke, DVT/ ... Splenomegaly Diagnosis ... A conclusive diagnosis ... • Treatment algorithms ... Hydroxyurea + anticoagulation